Google
LNAI — LUNAI BIOWORKS INC. (Healthcare >> Biotechnology)
LNAI FAQ
What is LNAI's P/E ratio?
LUNAI BIOWORKS INC. (LNAI) currently trades at a P/E ratio of 4.62.
What is LNAI's ROE?
LUNAI BIOWORKS INC. reports a Return on Equity (ROE) of 1,342.81%.
What is LNAI's dividend yield?
LUNAI BIOWORKS INC. offers a dividend yield of 0.00%.
What is LNAI's Deepscope Quality Score?
Deepscope rates LNAI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy LNAI?
Deepscope's AI Timing Score for LNAI is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does LNAI belong to?
LUNAI BIOWORKS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.45
Price
-0.47
(-16.10%)
Day Change
|
|
|---|
LNAI, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.45 |
| PBV / Sector |
-1.36 / 4.63
|
| Earning Per Share | -24.15 |
| PE / Sector |
4.62 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.70 / 0.53
|
| Average 1M Daily Value |
0.37 M
GREAT
|
| Average 1W Daily Value |
0.19 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:08:42 |
| Symbol | LNAI |
| Name | LUNAI BIOWORKS INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 4.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 13.01 / 8,857.28 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2080 Century Park East, Los Angeles, CA, United States, 90067
Phone: 305 918 1980
Website: https://www.lunaibioworks.com
Sector: Healthcare >> Biotechnology
Description: Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
